Shortage of Adderall Affecting Behavior in Children and Adults

On October 12, 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of a drug formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall. Adderall is an FDA approved drug for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD), including anger, anxiety, forgetfulness and trouble focusing.1 Adderall […]

FDA Approves Medical Device to Treat Children With ADHD

Story Highlights The FDA recently approved a medical device known as called Monarch external Trigeminal Nerve Stimulation System (eTNS) for treating children diagnosed with ADHD. The methodology of the clinical trial used to test the safety and efficacy of the electrical nerve stimulation device was flawed, which has raised concerns about safety. There are glaring […]